NCT01254474 Evaluation of Depolarization and Repolarisation Activity During Cardiac Arrhythmia Using a Novel Monophasic Action Potential Catheter Status COMPLETED Phase NA
NCT01235130 Multi_center Study to Evaluate the Effect of N-3 Fatty Acids (OMEGA-3) on Arrhythmia Recurrence in Atrial Fibrillation Status COMPLETED Phase PHASE3
NCT01233648 Resync-AF (Rate vs Rhythm Control in AF Patients With CRT-D) Status COMPLETED Phase PHASE4
NCT01233635 Secondary Prevention of Atrial Fibrillation (Impact of Renin-Angiotensin-Aldosterone System Inhibition) Status TERMINATED Phase PHASE4
NCT01229475 Stepwise Approach Versus Linear Ablation in Patients With Recurrence of Persistent Atrial Fibrillation Status UNKNOWN Phase NA
NCT01229254 Evaluate the Pharmacokinetics and Safety of MK-4448 in Participants With Nonvalvular Atrial Fibrillation or Atrial Flutter Status COMPLETED Phase PHASE2
NCT01229033 Ablating Atrial Tachycardias Occuring During Ablation of Complex Fractionated Electrograms in Persistent AF Status COMPLETED Phase NA
NCT01227629 PETRO Stroke Prevention in Patients With AF by Treatment With Dabigatran, With and Without Aspirin, Compared to Warfarin Status COMPLETED Phase PHASE2
NCT01224574 To Assess the Predictive Value of D-dimer Level on the Occurrence of Cardiovascular Events Status COMPLETED Phase N/A
NCT01213368 Dose Ranging Study of Dronedarone for the Control of Ventricular Rate in Japanese Patients With Permanent Atrial Fibrillation Status COMPLETED Phase PHASE2
NCT01206452 Oral Steroids Before Pulmonary Vein Isolation to Improve Outcomes Status COMPLETED Phase PHASE4
NCT01203748 Substrate and Trigger Ablation for Reduction of Atrial Fibrillation Trial - Star AF II Study Status COMPLETED Phase NA
NCT01199081 Pharmacokinetics and Optimal Timing of Dronedarone Initiation Following Long-term Amiodarone in Patients With Paroxysmal or Persistent Atrial Fibrillation Status COMPLETED Phase PHASE4
NCT01198873 Effects of Dronedarone on Cardiac Geometry and Function in Patients With Atrial Fibrillation and Left Atrial Enlargement Status TERMINATED Phase PHASE4
NCT01198275 n-3 Polyunsaturated Fatty Acids (PUFAs) in the Prevention of Atrial Fibrillation Status COMPLETED Phase PHASE3